Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Deploying an RNA-Based Gene Writer System and Lipid Nanoparticle (LNP) Delivery to Generate Functional Chimeric Antigen Receptor (CAR) T Cells with in Vitro and In Vivo Anti-Tumor Activity

Michael S Magee, Alberto De Iaco, Jason Rodriguez, James B. Rottman, Donghui Liu, Giulia Schiroli, Pooja Sabhachandani, Yu Cao, Rebecca Levy, Mohit Gupta, Michael T. Monte, Jane Wang, Bill Querbes, Cecilia Cotta-Ramusino, Madhusudan V Peshwa, Michael C Holmes

Blood (2023) 142 (Supplement 1): 2073.

https://doi.org/10.1182/blood-2023-184755

Published: 2023

Journal Articles

Clinical-Grade mRNA Electroporation of NK Cells: A Novel and Highly Efficient Method to Genetically Reprogram Human NK Cells for Cancer Immunotherapy

Mattias Carlsten, MD PhD, Linhong Li, Su Su, MD PhD, Maria Berg, Robert Reger, Madhusudan V. Peshwa, Richard Childs, MD

Blood (2014) 124 (21): 2153.

https://doi.org/10.1182/blood.V124.21.2153.2153

Published: 2014

Journal Articles

A Highly Efficient, Clinically Applicable Transfection Method to Redirect the Specificity of Immune Cells and Enhance Their Anti-Tumor Capacity

Linhong Li, PhD, Lawrence Wolfraim, PhD, Cornell Allen, Angelia Viley, Hiroyuki Fujisaki, Dario Campana, MD., PhD, Joseph C. Fratantoni, MD, Madhusudan V Peshwa, PhD

Blood (2008) 112 (11): 3894.

https://doi.org/10.1182/blood.V112.11.3894.3894

Published: 2008

Journal Articles

Vaccination Strategies for Patients with B-CLL.

Fatma V Okur, MD, Eric Yvon, MS, Gianpietro Dotti, MD, George Carrum, MD, Helen E. Heslop, MD, Malcolm K Brenner, MD, PhD, Joseph C. Fratantoni, MD, Madhusudan V Peshwa, PhD, Linhong Li, PhD

Blood (2008) 112 (11): 2106.

https://doi.org/10.1182/blood.V112.11.2106.2106

Published: 2008

Journal Articles

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Joseph C. Fratantoni, MD, Linhong Li, PhD, Linda N. Liu, PhD, Madhusudan V. Peshwa, PhD, Malcolm Brenner, MD, PhD, Eric Yvon, MS, George Carrum, MD, Ettore Biagi, MD

Blood (2005) 106 (11): 450.

https://doi.org/10.1182/blood.V106.11.450.450

Published: 2005

NARROW

Deploying an RNA-Based Gene Writer System and Lipid Nanoparticle (LNP) Delivery to Generate Functional Chimeric Antigen Receptor (CAR) T Cells with in Vitro and In Vivo Anti-Tumor Activity

Clinical-Grade mRNA Electroporation of NK Cells: A Novel and Highly Efficient Method to Genetically Reprogram Human NK Cells for Cancer Immunotherapy

A Highly Efficient, Clinically Applicable Transfection Method to Redirect the Specificity of Immune Cells and Enhance Their Anti-Tumor Capacity

Vaccination Strategies for Patients with B-CLL.

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Email alerts

ASH Publications

American Society of Hematology

Deploying an RNA-Based Gene Writer System and Lipid Nanoparticle (LNP) Delivery to Generate Functional Chimeric Antigen Receptor (CAR) T Cells with in Vitro and In Vivo Anti-Tumor Activity

Clinical-Grade mRNA Electroporation of NK Cells: A Novel and Highly Efficient Method to Genetically Reprogram Human NK Cells for Cancer Immunotherapy

A Highly Efficient, Clinically Applicable Transfection Method to Redirect the Specificity of Immune Cells and Enhance Their Anti-Tumor Capacity

Vaccination Strategies for Patients with B-CLL.

A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only